Nora Watman

1.1k total citations
30 papers, 719 citations indexed

About

Nora Watman is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Nora Watman has authored 30 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 11 papers in Molecular Biology and 9 papers in Organic Chemistry. Recurrent topics in Nora Watman's work include Lysosomal Storage Disorders Research (21 papers), Carbohydrate Chemistry and Synthesis (9 papers) and Glycosylation and Glycoproteins Research (8 papers). Nora Watman is often cited by papers focused on Lysosomal Storage Disorders Research (21 papers), Carbohydrate Chemistry and Synthesis (9 papers) and Glycosylation and Glycoproteins Research (8 papers). Nora Watman collaborates with scholars based in Argentina, United States and Russia. Nora Watman's co-authors include Elena Lukina, Hanna Rosenbaum, Marta Dragosky, Elsa Ávila Arreguin, Michel Peterschmitt, Ana Cristina Puga, Gregory M. Pastores, Daniel I. Rosenthal, Mici Phillips and Mathilde Kaper and has published in prestigious journals such as Blood, Osteoporosis International and Cellular Immunology.

In The Last Decade

Nora Watman

28 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nora Watman Argentina 12 570 277 256 238 212 30 719
Marta Dragosky Argentina 9 415 0.7× 196 0.7× 191 0.7× 171 0.7× 167 0.8× 23 499
R J Desnick United States 12 778 1.4× 309 1.1× 198 0.8× 205 0.9× 245 1.2× 20 941
Daniel Oder Germany 12 748 1.3× 351 1.3× 232 0.9× 246 1.0× 169 0.8× 26 828
Carmela Zizzo Italy 14 384 0.7× 140 0.5× 122 0.5× 117 0.5× 137 0.6× 34 490
Juan M. Mucci Argentina 12 286 0.5× 78 0.3× 44 0.2× 92 0.4× 127 0.6× 18 348
A Mehta United Kingdom 11 587 1.0× 248 0.9× 138 0.5× 210 0.9× 99 0.5× 36 688
Masahisa Kobayashi Japan 15 427 0.7× 212 0.8× 122 0.5× 131 0.6× 113 0.5× 38 564
Gabriela Pasqualim Brazil 13 258 0.5× 114 0.4× 54 0.2× 64 0.3× 155 0.7× 31 397
Karelle Bénistan France 10 405 0.7× 216 0.8× 121 0.5× 150 0.6× 133 0.6× 31 599
H.C. Janse Netherlands 11 268 0.5× 96 0.3× 63 0.2× 84 0.4× 127 0.6× 17 404

Countries citing papers authored by Nora Watman

Since Specialization
Citations

This map shows the geographic impact of Nora Watman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Watman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Watman more than expected).

Fields of papers citing papers by Nora Watman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Watman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Watman. The network helps show where Nora Watman may publish in the future.

Co-authorship network of co-authors of Nora Watman

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Watman. A scholar is included among the top collaborators of Nora Watman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Watman. Nora Watman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lukina, Elena, Nora Watman, Marta Dragosky, et al.. (2018). Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trial. American Journal of Hematology. 94(1). 29–38. 49 indexed citations
2.
Cançado, Rodolfo Delfini, Nora Watman, Clarisse Lobo, et al.. (2018). Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study. Hematology. 23(9). 676–682. 11 indexed citations
3.
González, Jacqueline, et al.. (2017). Influence of TNF and IL6 gene polymorphisms on the severity of cytopenias in Argentine patients with myelodysplastic syndromes. Annals of Hematology. 96(8). 1287–1295. 5 indexed citations
4.
Pinheiro, Ronald Feitosa, Irene Larripa, Jacqueline González, et al.. (2015). Myelodysplastic syndromes in South America: A multinational study of 1080 patients. American Journal of Hematology. 90(10). 851–858. 12 indexed citations
5.
Lukina, Elena, Nora Watman, Marta Dragosky, et al.. (2014). Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4 years of treatment. Blood Cells Molecules and Diseases. 53(4). 274–276. 61 indexed citations
6.
Kamath, Ravi S., Elena Lukina, Nora Watman, et al.. (2014). Skeletal improvement in patients with Gaucher disease type 1: a phase 2 trial of oral eliglustat. Skeletal Radiology. 43(10). 1353–1360. 47 indexed citations
7.
Peterschmitt, Michel, Elena Lukina, Nora Watman, et al.. (2012). Eliglustat, an Investigational Oral Therapy for Gaucher Disease Type 1: Phase 2 Results After 4 Years of Treatment. Blood. 120(21). 1038–1038. 2 indexed citations
8.
Peterschmitt, Michel, Elena Lukina, Nora Watman, et al.. (2011). Eliglustat, An Investigational Oral Therapy for Gaucher Disease Type 1: Phase 2 Results After 3 Years. Blood. 118(21). 1104–1104. 2 indexed citations
9.
Watman, Nora, et al.. (2011). Partial and total monosomal karyotypes in myelodysplastic syndromes: Comparative prognostic relevance among 421 patients. American Journal of Hematology. 86(7). 540–545. 22 indexed citations
10.
Peterschmitt, Michel, Ravi S. Kamath, Elena Lukina, et al.. (2011). Improvements in Skeletal Manifestations in Gaucher Disease Type 1 Patients After 3 Years of Treatment with Oral Eliglustat During a Phase 2 Trial,. Blood. 118(21). 3216–3216. 1 indexed citations
11.
Watman, Nora, et al.. (2011). The presence of -308A TNFα is associated with anemia and thrombocytopenia in patients with myelodysplastic syndromes. Blood Cells Molecules and Diseases. 47(4). 255–258. 6 indexed citations
12.
Puga, Ana Cristina, Elena Lukina, Nora Watman, et al.. (2011). Eliglustat, an investigational oral therapy for gaucher disease type 1 (GD1): Phase 2 results and assessment of patient responses and achievement of established therapeutic goals after 2 years of treatment. Molecular Genetics and Metabolism. 102(2). S37–S37. 2 indexed citations
13.
Mastaglia, Silvina Rosana, Nora Watman, & Beatriz Oliveri. (2010). Intravenous bisphosphonate treatment and pregnancy: its effects on mother and infant bone health. Osteoporosis International. 21(11). 1959–1962. 20 indexed citations
14.
Lukina, Elena, Nora Watman, Elsa Ávila Arreguin, et al.. (2010). A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1. Blood. 116(6). 893–899. 120 indexed citations
15.
Mistry, Pramod K., Maria Domenica Cappellini, Elena Lukina, et al.. (2010). A reappraisal of Gaucher disease—diagnosis and disease management algorithms. American Journal of Hematology. 86(1). 110–115. 122 indexed citations
16.
Lukina, Elena, Nora Watman, Elsa Ávila Arreguin, et al.. (2009). Genz-112638 for Gaucher Disease Type 1: Phase 2 Clinical Trial Results After 18 Months of Treatment.. Blood. 114(22). 1349–1349. 3 indexed citations
17.
Lukina, Elena, Nora Watman, Elsa Ávila Arreguin, et al.. (2009). 102. Genz-112638, an investigational oral treatment for Gaucher disease type 1: Preliminary Phase 2 clinical trial results. Molecular Genetics and Metabolism. 96(2). S34–S34.
18.
Mistry, Pramod K., Maria Domenica Cappellini, Elena Lukina, et al.. (2008). Diagnostic and Disease Management Algorithms for Gaucher Disease: A Guide for Haematologists. Blood. 112(11). 4648–4648.
19.
Cohen, Alan R., Giuseppe Masera, N. Zoumbos, et al.. (2005). Effect of Iron Intake on Control of Body Iron in Patients with Thalassemia Major Treated with Deferasirox (Exjade®, ICL670).. Blood. 106(11). 822–822. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Dragosky Breakdown of academic impact, for papers by R J Desnick Breakdown of academic impact, for papers by Daniel Oder Breakdown of academic impact, for papers by Carmela Zizzo Breakdown of academic impact, for papers by Juan M. Mucci Breakdown of academic impact, for papers by A Mehta Breakdown of academic impact, for papers by Masahisa Kobayashi Breakdown of academic impact, for papers by Gabriela Pasqualim Breakdown of academic impact, for papers by Karelle Bénistan Breakdown of academic impact, for papers by H.C. Janse
Rankless by CCL
2026